long-term follow-up

Original Contribution

Ten-Year Clinical Outcomes in Patients With Acute Coronary Syndrome Treated With Biodegradable, Permanent-Polymer or Polymer-Free Drug-Eluting Stents

04/01/2022

J.J. Coughlan, MB, BCh^1,4*; Alp Aytekin, MD^1*; Tobias Lenz, MD¹; Tobias Koch, MD¹; Jens Wiebe, MD¹; Salvatore Cassese, MD, PhD¹; Michael Joner, MD^1,3; Tobias Koppara, MD²; Erion Xhepa, MD, PhD¹; Thorsten Kessler, MD¹; Tareq Ibrahim, MD²; Karl-Ludwig Laugwitz, MD^2,3; Heribert Schunkert, MD^1,3; Adnan Kastrati, MD^1,3; Sebastian Kufner, MD¹

J.J. Coughlan, MB, BCh1,4*; Alp Ayte...

This study aimed to compare 10-year clinical outcomes in patients with acute coronary syndrome (ACS) treated with new-generation biodegradable-polymer (BP-DES), polymer-free (PF-DES), and permanent-polymer drug-eluting stents (PP-DES).

This study aimed to compare...

04/01/2022

Journal of Invasive Cardiology

A Case of Very Late Stent Thrombosis 11 Years After Drug-Eluting Stent Implantation

07/23/2019

Rajesh Vijayvergiya, MD; Basant Kumar, MD; Ganesh Kasinadhuni, MD; Soumitra Mohanty, MD

Rajesh Vijayvergiya, MD; Basant Kuma...

Eleven years after DES implantation, a patient presented with AMI despite continued dual-antiplatelet therapy. Coronary angiography revealed total occlusion of the proximal LAD.

Eleven years after DES...

07/23/2019

Journal of Invasive Cardiology